Mar 24, 2020

Royal Commission Extends Deadline For Submissions

In a recent media release, The Royal Commission into Aged Care Quality and Safety has revealed that they will suspend all hearings and workshops, for the time being, subject to ongoing review.

This decision is a consequence of the evolving coronavirus (COVID-19) pandemic, and based on information available from the Australian Government and affects all hearings and workshops scheduled until at least the end of May 2020.

The suspension also applies to all group consultations which have been part of the engagement work conducted by Royal Commission staff.

The Commissioners are considering the implications of this decision on the continuing work program of the Royal Commission.

Given the continuing effects of the COVID-19 pandemic, the deadline for submissions is subject to continual monitoring.

For more information read the media release and visit the about the Coronavirus and the Aged Care Royal Commission page.

Leave a Reply

Your email address will not be published. Required fields are marked *

Advertisement
Advertisement
Advertisement

Falls are more likely when you’ve had a bad night’s sleep

Just one night of disturbed sleep means you are less capable to control posture and balance the day after. A single bad night sleep decreases your chance of controlling posture according to researchers at the University of Warwick, who have used state of the art sensors to monitor sleep and balance. Implications could be that... Read More

92-Year-Old Man Drives His Mobility Scooter Down 100Km/h Freeway

Anyone who travels via motorbike or drives a convertible car will tell you that there is nothing quite like the sense of adventure that comes from feeling the wind on your face as you hit the open road, and apparently, these feelings are not limited by age. A driver by the name of Bruce Bromley... Read More

Why it’s time to treat medicinal cannabis as an alternative therapy – not a pharmaceutical

The recent approval of two domestically produced cannabidiol (CBD) oil products – non-intoxicating cannabis compounds – may have provided new optimism to patients on cannabis prescriptions. Read More
Advertisement